{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:47:39Z","timestamp":1790380059421,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"UN"},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"QREN"},{"DOI":"10.13039\/501100008530","name":"European Fund for Regional Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"COMPETE","doi-asserted-by":"publisher","award":["PEst C-QUI\/UI0062\/2019"],"award-info":[{"award-number":["PEst C-QUI\/UI0062\/2019"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"COMPETE","doi-asserted-by":"publisher","award":["FCOMP-01-0124-FEDER-037296"],"award-info":[{"award-number":["FCOMP-01-0124-FEDER-037296"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ejmech.2019.111660","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T12:38:22Z","timestamp":1567082302000},"page":"111660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-970X","authenticated-orcid":false,"given":"Susana Santos","family":"Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111660_bib1","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.ejmech.2019.111660_bib2","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.ejmech.2019.111660_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2019.111660_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/835910","article-title":"Natural products: insights into leishmaniasis inflammatory response","author":"Rodrigues","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2019.111660_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000585","article-title":"Climate change and risk of leishmaniasis in north America: predictions from ecological Niche models of vector and reservoir species","volume":"4","author":"Gonz\u00e1lez","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tmaid.2014.09.007","article-title":"Leishmaniasis in travellers: a literature review","volume":"12","author":"Mansueto","year":"2014","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1590\/S0074-02762007000500001","article-title":"The leishmaniases - survival and expansion in a changing world. A mini-review","volume":"102","author":"Shaw","year":"2007","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2019.111660_bib8","series-title":"Global Health \u2013 Division of Parasitic Diseases: Parasites \u2013 Leishmaniasis. Resources for Health Professionals","year":"2017"},{"key":"10.1016\/j.ejmech.2019.111660_bib9","first-page":"1455","article-title":"Cutaneous leishmaniasis: recognition and treatment","volume":"69","author":"Markle","year":"2004","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ejmech.2019.111660_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1590\/S0074-02762003000900029","article-title":"Pathoecology of Chiribaya parasitism","volume":"98","author":"Martinson","year":"2003","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2019.111660_bib11","series-title":"Leishmaniasis Key Facts","author":"World Health Organization (WHO)","year":"2018"},{"key":"10.1016\/j.ejmech.2019.111660_bib12","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3389\/fimmu.2017.01492","article-title":"Immune checkpoint targets for host-directed therapy to prevent and treat leishmaniasis","volume":"8","author":"Kumar","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2019.111660_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005706","article-title":"Collaborative LV Brasil Group, Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: a multicenter, randomized, open label trial","volume":"11","author":"Romero","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/EC.00041-08","article-title":"Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance","volume":"7","author":"Cowen","year":"2008","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ejmech.2019.111660_bib15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/BF02537115","article-title":"Sterol synthesis and viability of erg11 (cytochrome P450 lanosterol demethylase) mutations in Saccharomyces cerevisiae and Candida albicans","volume":"28","author":"Bard","year":"1993","journal-title":"Lipids"},{"key":"10.1016\/j.ejmech.2019.111660_bib16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/21505594.2016.1188236","article-title":"The synthesis, regulation, and functions of sterols in Candida albicans: well-known but still lots to learn","volume":"7","author":"Lv","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.ejmech.2019.111660_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/MMBR.00045-10","article-title":"Regulatory circuitry governing fungal development, drug resistance, and disease","volume":"75","author":"Shapiro","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmech.2019.111660_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001126","article-title":"Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi","volume":"6","author":"Mansfield","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2019.111660_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2019.111660_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1471-4914(02)02280-3","article-title":"Molecular basis of resistance to azole antifungals","volume":"8","author":"Lupetti","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2019.111660_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000939","article-title":"Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs","volume":"6","author":"Zhang","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2019.111660_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003588","article-title":"Targeting ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14alpha-demethylase","volume":"9","author":"McCall","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib23","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2174\/156802611796575902","article-title":"Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis","volume":"11","author":"Lepesheva","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111660_bib24","series-title":"Cytochrome P450: Structure, Mechanism, and Biochemistry","first-page":"305","article-title":"Inhibition of cytochrome P450 enzymes","author":"Ortiz de Montellano","year":"1995"},{"key":"10.1016\/j.ejmech.2019.111660_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0166-6851(88)90166-1","article-title":"Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes","volume":"31","author":"Beach","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2019.111660_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/14756360600700517","article-title":"Antileishmanial activities and mechanisms of action of indole-based azoles","volume":"21","author":"Pagniez","year":"2006","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111660_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083247","article-title":"In\u00a0vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis","volume":"8","author":"de Macedo-Silva","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111660_bib28","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1128\/AAC.01545-16","article-title":"Antileishmanial activity of ezetimibe: inhibition of sterol biosynthesis, in\u00a0vitro synergy with azoles, and efficacy in experimental cutaneous leishmaniasis","volume":"60","author":"Andrade-Neto","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib29","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4269\/ajtmh.16-0373","article-title":"In\u00a0vitro sensitivity of cutaneous leishmania promastigote isolates circulating in French Guiana to a set of drugs","volume":"96","author":"Ginouv\u00e8s","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2019.111660_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-4632.2004.02429.x","article-title":"Cutaneous leishmaniasis: successful treatment with itraconazole","volume":"45","author":"Consigli","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejmech.2019.111660_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1201-9712(00)90077-8","article-title":"Use of itraconazole in the treatment of mucocutaneous leishmaniasis: a pilot study","volume":"4","author":"Amato","year":"2000","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09546630152607899","article-title":"Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis","volume":"12","author":"Salmanpour","year":"2001","journal-title":"J.\u00a0Dermatol. Treat."},{"key":"10.1016\/j.ejmech.2019.111660_bib33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2010.04.014","article-title":"Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous Leishmania major infection: a randomized clinical trial","volume":"64","author":"Emad","year":"2011","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.ejmech.2019.111660_bib34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/cid\/cir496","article-title":"High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to leishmania (Vianna) braziliensis","volume":"53","author":"Sousa","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib35","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"Gray","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2019.111660_bib36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1749-6632.1974.tb43283.x","article-title":"The structure and function of AmB-cholesterol pores in lipid bilayermembranes","volume":"235","author":"Andreoli","year":"1974","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2019.111660_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-4157(86)90002-X","article-title":"How do polyene macrolide antibiotics affect the cellular membrane properties?","volume":"864","author":"Bolard","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2019.111660_bib38","doi-asserted-by":"crossref","first-page":"8494","DOI":"10.1021\/bi900578y","article-title":"Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae","volume":"48","author":"Abe","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2019.111660_bib39","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1128\/AAC.49.6.2226-2236.2005","article-title":"Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans","volume":"49","author":"Liu","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1099\/jmm.0.015784-0","article-title":"Apoptosis in Candida biofilms exposed to amphotericin","volume":"59","author":"Al-Dhaheri","year":"2010","journal-title":"Bangladesh J. Med. Microbiol."},{"key":"10.1016\/j.ejmech.2019.111660_bib41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: dose and response","volume":"2","author":"Sundar","year":"2010","journal-title":"J.\u00a0Glob. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10847-019-00885-y","article-title":"Treating an old disease with new tricks: strategies based on host\u2013guest chemistry for leishmaniasis therapy","volume":"93","author":"Braga","year":"2019","journal-title":"J.\u00a0Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.111660_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijpddr.2017.09.003","article-title":"L-Asparaginase of Leishmania donovani: metabolic target and its role in Amphotericin B resistance","volume":"7","author":"Singh","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2019.111660_bib44","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.00214-13","article-title":"Attenuation of leishmania infantum chagasi metacyclic promastigotes by sterol depletion","volume":"81","author":"Yao","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2019.111660_bib45","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib46","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/AAC.49.8.3274-3280.2005","article-title":"Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana","volume":"49","author":"Al-Mohammed","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.42.2.352","article-title":"Mechanism of amphotericin B resistance in Leishmania donovani promastigotes","volume":"42","author":"Mbongo","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005649","article-title":"Sterol 14\u00e1-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana","volume":"11","author":"Mwenechanya","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib49","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/AAC.02834-14","article-title":"Ascorbate peroxidase, a key molecule regulating amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"58","author":"Kumar","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pt.2006.12.003","article-title":"Cholesterol: a potential therapeutic target in Leishmania infection?","volume":"23","author":"Pucadyil","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2019.111660_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbrc.2010.07.099","article-title":"Amphotericin B inhibits entry of Leishmania donovani into primary macrophages","volume":"399","author":"Paila","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2019.111660_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2011.11.023","article-title":"A\u00a0novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis","volume":"416","author":"Chattopadhyay","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2019.111660_bib53","doi-asserted-by":"crossref","first-page":"37561","DOI":"10.1074\/jbc.M306137200","article-title":"The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism","volume":"278","author":"Sau","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111660_bib54","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1086\/315835","article-title":"Amphotericin B induces expression of genes encoding chemokines and cell adhesion molecules in the human monocytic cell line THP-1","volume":"182","author":"Rogers","year":"2000","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fmicb.2012.00286","article-title":"It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug","volume":"3","author":"Mesa-Arango","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2019.111660_bib56","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1124\/mol.62.4.936","article-title":"Revisiting an old antimicrobial drug: amphotericin B induces interleukin-1-converting enzyme as the main factor for inducible nitric-oxide synthase expression in activated endothelia","volume":"62","author":"Suschek","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111660_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0005-2760(94)90133-3","article-title":"Uptake, subcellular distribution and metabolism of the phospholipid analogue hexadecylphosphocholine in MDCK cells","volume":"1211","author":"Geilen","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2019.111660_bib58","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1016\/S0021-9258(19)50485-9","article-title":"Hexadecylphosphocholine inhibits translocation of CTP:choline-phosphate cytidylyltransferase in Madin-Darby canine kidney cells","volume":"267","author":"Geilen","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111660_bib59","doi-asserted-by":"crossref","first-page":"14668","DOI":"10.1074\/jbc.271.25.14668","article-title":"A\u00a0genetic defect in phosphatidylcholine biosynthesis triggers apoptosis in Chinese hamster ovary cells","volume":"271","author":"Cui","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111660_bib60","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0006-2952(01)00715-8","article-title":"Effects of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities","volume":"62","author":"Rybczynska","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111660_bib61","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1471-4159.2008.05625.x","article-title":"Involvement of miltefosine-mediated ERK activation in glioma cell apoptosis through Fas regulation","volume":"107","author":"Tewari","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.111660_bib62","first-page":"4027","article-title":"Changes of intracellular calcium, fatty acids and phospholipids during miltefosine-induced apoptosis monitored by fluorescence and 13C NMR-spectroscopy","volume":"19","author":"Henke","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2019.111660_bib63","first-page":"101","article-title":"The interference effects of hexadecylphosphocholine on proliferation and membrane phospholipid metabolism in human myeloid leukaemia cell lines","volume":"20","author":"Wang","year":"1998","journal-title":"Int. J. Tissue React."},{"key":"10.1016\/j.ejmech.2019.111660_bib64","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1074\/jbc.273.18.11025","article-title":"Induction of ceramide mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine","volume":"273","author":"Wieder","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111660_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000709","article-title":"Why miltefosine\u2014a life-saving drug for leishmaniasis\u2014is unavailable to people who need it the most","volume":"3","author":"Sunyoto","year":"2018","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.ejmech.2019.111660_bib66","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.48.3.852-859.2004","article-title":"Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes","volume":"48","author":"Paris","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib67","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1590\/S0074-02762011000400021","article-title":"Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes","volume":"106","author":"Marinho","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2019.111660_bib68","first-page":"23","article-title":"Induction of apoptosis by miltefosine in Iranian strain of Leishmania infantum promastigotes","volume":"4","author":"Khademvatan","year":"2009","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.ejmech.2019.111660_bib69","first-page":"442","article-title":"Miltefosine induces metacaspase and PARP genes expression in Leishmania infantum","volume":"15","author":"Khademvatan","year":"2011","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41598-017-00186-9","article-title":"Methionine aminopeptidase 2 is a key regulator of apoptotic like cell death in Leishmania donovani","volume":"7","author":"Kumar","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.111660_bib71","first-page":"60","article-title":"Leishmanicidal activity of edelfosine, miltefosine and ilmofosine","volume":"96","author":"Azzouz","year":"2005","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2019.111660_bib72","first-page":"e01614","article-title":"Mechanism of action of miltefosine on Leishmania donovani involves the impairment of acidocalcisome function and the activation of the sphingosine-dependent plasma membrane Ca2+ channel","volume":"62","author":"Pinto-Martinez","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib73","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbrc.2012.12.033","article-title":"Identification of a sphingosine-sensitive Ca2+ channel in the plasma membrane of Leishmania mexicana","volume":"430","author":"Benaim","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2019.111660_bib74","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/proteomes3040328","article-title":"Mitochondrial proteomics of antimony and miltefosine resistant Leishmania infantum","volume":"3","author":"Vincent","year":"2015","journal-title":"Proteomes"},{"key":"10.1016\/j.ejmech.2019.111660_bib75","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01415-06","article-title":"Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes","volume":"51","author":"Luque-Ortega","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib76","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/mol.111.072322","article-title":"Miltefosine induces apoptosis-like cell death in yeast via Cox9p in cytochrome c oxidase","volume":"80","author":"Zuo","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111660_bib77","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jac\/dkh380","article-title":"Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis","volume":"54","author":"Santa-Rita","year":"2004","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib78","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.4049\/jimmunol.0803859","article-title":"Miltefosine promotes IFN-\u03b3-Dominated anti-leishmanial immune response","volume":"182","author":"Wadhone","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.111660_bib79","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/jid.2008.248","article-title":"Miltefosine inhibits human mast cell activation and mediator release both in\u00a0vitro and in\u00a0vivo","volume":"129","author":"Weller","year":"2008","journal-title":"J.\u00a0Investig. Dermatol."},{"key":"10.1016\/j.ejmech.2019.111660_bib80","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.1159194","article-title":"In\u00a0vivo imaging reveals an essential role for neutrophils in Leishmaniasis transmitted by sand flies","volume":"321","author":"Peters","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.111660_bib81","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.4049\/jimmunol.152.9.4563","article-title":"Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse","volume":"152","author":"Wershil","year":"1994","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.111660_bib82","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-3024.2008.01084.x","article-title":"Mast cell degranulation contributes to susceptibility to Leishmania major","volume":"31","author":"Rom\u00e3o","year":"2009","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ejmech.2019.111660_bib83","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/eji.201545613","article-title":"Mast cells have no impact on cutaneous leishmaniasis severity and related Th2 differentiation in resistant and susceptible mice","volume":"46","author":"Paul","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejmech.2019.111660_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005706","article-title":"The Collaborative LVBrasil Group, Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: a multicenter, randomized, open label trial","volume":"11","author":"Romero","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2018.09.029","article-title":"A\u00a0Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis","volume":"36","author":"Carnielli","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2019.111660_bib86","first-page":"425","article-title":"The in\u00a0Vitro effect of clarithromycin on amastigote of Leishmania donovani","volume":"5","author":"Roy","year":"2003","journal-title":"Int. J. Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2019.111660_bib87","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF02256576","article-title":"Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis","volume":"9","author":"Zhang","year":"2002","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.ejmech.2019.111660_bib88","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1128\/AAC.00945-16","article-title":"Inhibition of Leishmania mexicana growth by the tuberculosis drug SQ109","volume":"60","author":"Garc\u00eda-Garc\u00eda","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib89","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1172\/JCI41281","article-title":"Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice","volume":"120","author":"Dalton","year":"2010","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ejmech.2019.111660_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000249","article-title":"Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice","volume":"2","author":"Miguel","year":"2008","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2019.111660_bib91","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jac\/dkm219","article-title":"Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes","volume":"60","author":"Miguel","year":"2007","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib92","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/AAC.01315-13","article-title":"Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis","volume":"58","author":"Trinconi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib93","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jac\/dkv495","article-title":"Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis","volume":"71","author":"Trinconi","year":"2016","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.111660_bib94","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1021\/jm9004835","article-title":"Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania","volume":"52","author":"Cavalli","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111660_bib95","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.bmc.2010.01.068","article-title":"Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species","volume":"18","author":"Prado-Prato","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111660_bib96","series-title":"Drug Discovery for Leishmaniasis","first-page":"130","article-title":"In Silico tools for target identification and drug molecular docking in Leishmania","author":"Roca","year":"2017"},{"key":"10.1016\/j.ejmech.2019.111660_bib97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11030-010-9280-3","article-title":"First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in\u00a0vitro, in\u00a0vivo, and in different cellular lines","volume":"15","author":"Garc\u00eda","year":"2011","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2019.111660_bib98","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.2174\/1381612822666160513144853","article-title":"Structure- and ligand-based approaches to evaluate aporphynic alkaloids from annonaceae as multi-target agent against Leishmania donovani","volume":"22","author":"Lorenzo","year":"2016","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.111660_bib99","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.3390\/molecules19055550","article-title":"In-silico analyses of sesquiterpene-related compounds on selected leishmania enzyme-based targets","volume":"19","author":"Bernal","year":"2014","journal-title":"Molecules"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419308049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419308049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:57:42Z","timestamp":1759327062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419308049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":99,"alternative-id":["S0223523419308049"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111660","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111660"}}